Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Response Evaluation”

Showing 20 of 0 results

Not applicableUnknownNCT02426645
What this trial is testing

Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction

Who this might be right for
SepsisMultiple Organ Failure
Prof. Dr. Marc-H. Dahlke, Ph. D. 25
Not applicableUnknownNCT01539551
What this trial is testing

Investigation of the Role of Brain Natriuretic Peptide and Lactate in Early Goal-directed Therapy for Patients With Severe Sepsis and Septic Shock

Who this might be right for
SepsisSeptic Shock
National Taiwan University Hospital 300
Not applicableStudy completedNCT07025603
What this trial is testing

Evaluation of the Social ABCs in Israel

Who this might be right for
AutismAutism Spectrum Disorder (ASD)
Hebrew University of Jerusalem 20
Large-scale testing (Phase 3)Study completedNCT01519791
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 880
Post-approval studies (Phase 4)UnknownNCT01835613
What this trial is testing

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Who this might be right for
Rheumatoid Arthritis (RA)
Osservatorio Epidemiologico GISEA 150
Not applicableStudy completedNCT01366157
What this trial is testing

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 23
Testing effectiveness (Phase 2)WithdrawnNCT01757899
What this trial is testing

Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children

Who this might be right for
Acute Lung InjuryAcute Respiratory Distress Syndrome
Universidade Federal do Rio de Janeiro
Not applicableUnknownNCT00258869
What this trial is testing

Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests

Who this might be right for
SepsisSepticemiaSepsis Syndrome+2 more
National Center for Genome Resources 1,200
Testing effectiveness (Phase 2)Study completedNCT02246595
What this trial is testing

Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction

Who this might be right for
Severe SepsisSeptic Shock
InflaRx GmbH 72
Post-approval studies (Phase 4)Study completedNCT04083612
What this trial is testing

Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 49
Post-approval studies (Phase 4)Study completedNCT04080661
What this trial is testing

Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 82
Not applicableStudy completedNCT03145428
What this trial is testing

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis

Who this might be right for
SepsisSevere Infection
Beckman Coulter, Inc. 3,000
Not applicableStudy completedNCT01650077
What this trial is testing

Therapeutic Response of Patients With Soft Tissue Sarcoma According to CHOI Criteria

Who this might be right for
Soft Tissue Sarcoma
Centre Oscar Lambret 134
Testing effectiveness (Phase 2)UnknownNCT04062656
What this trial is testing

Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG

Who this might be right for
Gastric CancerAdenocarcinoma of the Esophagogastric Junction
University Hospital, Essen 21
Post-approval studies (Phase 4)Study completedNCT04080648
What this trial is testing

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 79
Not applicableStudy completedNCT05584098
What this trial is testing

MEWS, qSOFA and Physiological Parameters Combination in the Emergency Room

Who this might be right for
Sepsis
St. Martin De Porress Hospital 950
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Post-approval studies (Phase 4)Ended earlyNCT02904876
What this trial is testing

Evaluation of Early Changes Visible to the Diffusion MRI in Response to Two Years of Treatment With Tysabri in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Strasbourg, France 70
Testing effectiveness (Phase 2)Study completedNCT00737438
What this trial is testing

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 22
Not applicableStudy completedNCT03904043
What this trial is testing

Non-Operative Management and Early Response Assessment in Rectal Cancer

Who this might be right for
Adenocarcinoma of the Lower Rectum
Washington University School of Medicine 63
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation